Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?

Source: cnbc November 9, 2026 · 05:27
Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?
Photo by David Peterson · Pexels
From the publisher
Novonesis is exploring whether gut health supplements could benefit patients taking GLP-1 weight-loss drugs, opening up a potentially lucrative new market.
About the source

CNBC

The Consumer News and Business Channel (CNBC) is an American business news channel owned by Versant. The network broadcasts live business news and analysis programming during the morning, daytime business day, and early-evening hours, with the remaining hours filled by business-related documentaries and reality television programming, as well as occasional sports presentations from USA Sports. CNBC operates an accompanying financial news website, CNBC.com, which includes news articles, video and…

Wikipedia
Wikidata Q1023912
Wikidata ↗

The original article opens on the publisher's website.

More from General

View topic →